Sort
48,018 grants matching “immunotherapy”
Western Regional Community Clinical Oncology Program
$365,000Banner Good Samaritan Medical Center · U10 · FY2005 · CA
VIRAHEP-C Clinical Center
$365,000University Of Michigan At Ann Arbor · U01 · FY2002 · DK
Oral Pathogens and Dendritic Cell Subsets
$364,975Christopher W Cutler · State University New York Stony Brook · R01 · FY2007 · DE
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$364,957Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2023 · CA
The CXCR3 Chemokine System in Cancer Immunotherapy
$364,930Andrew D Luster · Massachusetts General Hospital · R01 · FY2019 · CA
Role of IL-12 family cytokines in human autoimmune Uveitis
$364,919Charles E Egwuagu · National Eye Institute · ZIA · FY2017 · EY
RNase H2 is a novel therapeutic target in triple negative breast cancer
$364,910Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$364,880Hui Zhang · Washington State University · R01 · FY2023 · CA
Role of hybrid peptide specific T cells in diabetes
$364,861Brian T Fife · University Of Minnesota · P01 · FY2022 · AI
The Pancreatic Cancer Microenvironment
$364,845Rui Kang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Role of exosomal SPHK1 in ovarian cancer progression
$364,802Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2023 · CA
Immunobiology of Myeloid and Lymphoid Cells
$364,768Dartmouth College · T32 · FY2001 · AI
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
$364,751Michael H. A. Roehrl · Beth Israel Deaconess Medical Center · U01 · FY2024 · CA
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$364,720Adam M Sonabend · Northwestern University At Chicago · R01 · FY2024 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$364,720Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2024 · NS
CTLA-4 Blockade in GM-CSF Vaccinated Patients
$364,678Dana-Farber Cancer Institute · R21 · FY2004 · CA
CTLA-4 Blockade in GM-CSF Vaccinated Patients
$364,678Dana-Farber Cancer Institute · R21 · FY2003 · CA
Mechanism of Potent Neutralization of HIV by IgA CD4i Antibody
$364,644Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · AI
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$364,644John Tanner Wilson · Vanderbilt University · R01 · FY2022 · CA
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
$364,626Jerry D Glickson · University Of Pennsylvania · R01 · FY2010 · CA
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$364,612Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC
$364,593Lingtao Jin · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Pathogenesis of Experimental Autoimmune Myocarditis
$364,580David M. Engman · Northwestern University At Chicago · R01 · FY2009 · HL
Pathogenesis of Experimental Autoimmune Myocarditis
$364,580David M. Engman · Northwestern University At Chicago · R01 · FY2010 · HL
T Cell Reagent Research for Monitoring T Cell in Food Allergy
$364,563Kari C. Nadeau · Stanford University · U01 · FY2019 · AI